BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7827065)

  • 1. Pre-steady-state transition-state analysis of the hydrolytic reaction catalyzed by purine nucleoside phosphorylase.
    Kline PC; Schramm VL
    Biochemistry; 1995 Jan; 34(4):1153-62. PubMed ID: 7827065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction.
    Kline PC; Schramm VL
    Biochemistry; 1993 Dec; 32(48):13212-9. PubMed ID: 8241176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine nucleoside phosphorylase. Inosine hydrolysis, tight binding of the hypoxanthine intermediate, and third-the-sites reactivity.
    Kline PC; Schramm VL
    Biochemistry; 1992 Jul; 31(26):5964-73. PubMed ID: 1627539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition-state analysis of nucleoside hydrolase from Crithidia fasciculata.
    Horenstein BA; Parkin DW; Estupiñán B; Schramm VL
    Biochemistry; 1991 Nov; 30(44):10788-95. PubMed ID: 1931998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic alpha-deuterium isotope effects for Escherichia coli purine nucleoside phosphorylase-catalyzed phosphorolysis of adenosine and inosine.
    Stein RL; Cordes EH
    J Biol Chem; 1981 Jan; 256(2):767-72. PubMed ID: 6778874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calf spleen purine nucleoside phosphorylase: complex kinetic mechanism, hydrolysis of 7-methylguanosine, and oligomeric state in solution.
    Bzowska A
    Biochim Biophys Acta; 2002 Apr; 1596(2):293-317. PubMed ID: 12007610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis.
    Fedorov A; Shi W; Kicska G; Fedorov E; Tyler PC; Furneaux RH; Hanson JC; Gainsford GJ; Larese JZ; Schramm VL; Almo SC
    Biochemistry; 2001 Jan; 40(4):853-60. PubMed ID: 11170405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases.
    Lewandowicz A; Schramm VL
    Biochemistry; 2004 Feb; 43(6):1458-68. PubMed ID: 14769022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside hydrolase from Crithidia fasciculata. Metabolic role, purification, specificity, and kinetic mechanism.
    Parkin DW; Horenstein BA; Abdulah DR; Estupiñán B; Schramm VL
    J Biol Chem; 1991 Nov; 266(31):20658-65. PubMed ID: 1939115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin: transition state analysis for ADP-ribosylation of G-protein peptide alphai3C20.
    Scheuring J; Schramm VL
    Biochemistry; 1997 Jul; 36(27):8215-23. PubMed ID: 9204866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
    Miles RW; Tyler PC; Furneaux RH; Bagdassarian CK; Schramm VL
    Biochemistry; 1998 Jun; 37(24):8615-21. PubMed ID: 9628722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenate and phosphate as nucleophiles at the transition states of human purine nucleoside phosphorylase.
    Silva RG; Hirschi JS; Ghanem M; Murkin AS; Schramm VL
    Biochemistry; 2011 Apr; 50(13):2701-9. PubMed ID: 21348499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of nucleotides with specific radiolabels in ribose. Primary 14C and secondary 3H kinetic isotope effects on acid-catalyzed glycosidic bond hydrolysis of AMP, dAMP, and inosine.
    Parkin DW; Leung HB; Schramm VL
    J Biol Chem; 1984 Aug; 259(15):9411-7. PubMed ID: 6746654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic isotope effect characterization of the transition state for oxidized nicotinamide adenine dinucleotide hydrolysis by pertussis toxin.
    Scheuring J; Schramm VL
    Biochemistry; 1997 Apr; 36(15):4526-34. PubMed ID: 9109661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
    Gregus Z; Roos G; Geerlings P; Németi B
    Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine nucleoside phosphorylase as a cytosolic arsenate reductase.
    Gregus Z; Németi B
    Toxicol Sci; 2002 Nov; 70(1):13-9. PubMed ID: 12388830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calf spleen purine nucleoside phosphorylase complexed with substrates and substrate analogues.
    Mao C; Cook WJ; Zhou M; Federov AA; Almo SC; Ealick SE
    Biochemistry; 1998 May; 37(20):7135-46. PubMed ID: 9585525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic nature of the transition state for nucleoside hydrolase. A blueprint for inhibitor design.
    Horenstein BA; Schramm VL
    Biochemistry; 1993 Jul; 32(28):7089-97. PubMed ID: 8343502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote mutations alter transition-state structure of human purine nucleoside phosphorylase.
    Luo M; Li L; Schramm VL
    Biochemistry; 2008 Feb; 47(8):2565-76. PubMed ID: 18281957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer Simulations Reveal Substrate Specificity of Glycosidic Bond Cleavage in Native and Mutant Human Purine Nucleoside Phosphorylase.
    Isaksen GV; Hopmann KH; Åqvist J; Brandsdal BO
    Biochemistry; 2016 Apr; 55(14):2153-62. PubMed ID: 26985580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.